1606 CORP (CBDW) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 9, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CBDW SEC filings page.
1606 CORP (CBDW) reported $0 in revenue for fiscal year 2025, down 100.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The filings depict shrinking reported activity, severe balance-sheet strain, and limited evidence of operating cash conversion.
Reported revenue fell from$13.9M in FY2022 to$7.2M in FY2024, reducing the base available to absorb operating costs. Gross margin simultaneously moved from37.9% to-1.6% , indicating that the remaining sales no longer covered product costs.
By FY2025, liabilities of
In FY2022, the net loss of
Financial Health Signals
1606 CORP does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
1606 CORP reported -$121K in net income in Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Cash & Balance Sheet
1606 CORP held $288 in cash against $2.6M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
None of these metrics is reported for Q2 2026.
Capital Allocation
None of these metrics is reported for Q2 2026.
CBDW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24POS AM | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | $0 | $0 | $0-100.0% | N/A | $0-100.0% |
| Cost of Revenue | N/A | N/A | N/A | $0 | $0 | $0-100.0% | N/A | $0 |
| Gross Profit | N/A | N/A | N/A | $0 | $0 | $0+100.0% | N/A | $0-100.0% |
| SG&A Expenses | $155K+32.2% | $168K | N/A | N/A | $117K-59.4% | N/A | N/A | N/A |
| Operating Income | -$155K-32.2% | -$168K | N/A | N/A | -$117K+59.4% | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | $63K-50.9% | N/A | N/A | $98K+211.9% |
| Income Tax | $0 | $0 | N/A | $0 | $0 | $0 | N/A | $0 |
| Net Income | -$121K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.07 |
| Diluted Shares (Avg) | 1.05B | 604M | N/A | 178M | 144M | 124M | N/A | 51M |
Not reported in any period shown, so not listed: R&D Expenses, EBITDA, EPS (Basic).
CBDW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24POS AM | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $42K+55.4% | $70K+24627.4% | $16K+58.4% | $15K-66.7% | $27K-86.3% | $285-99.8% | $10K-93.2% | $44K-77.9% |
| Current Assets | $42K+55.4% | $70K+24627.4% | $16K+58.4% | $15K-66.7% | $27K-86.3% | $285-99.8% | $10K-93.2% | $44K-77.9% |
| Cash & Equivalents | $288-84.5% | $9K+3072.3% | $0-100.0% | $998-96.3% | $2K-97.5% | $285-98.2% | $2K-95.8% | $27K-22.0% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | $0-100.0% | $0-100.0% |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | $0-100.0% | $0-100.0% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $4.0M+54.8% | $4.2M+76.4% | $3.2M+46.8% | $2.9M+35.7% | $2.6M+21.3% | $2.4M+34.2% | $2.2M+41.1% | $2.1M+37.5% |
| Current Liabilities | $4.0M+54.8% | $4.2M+76.4% | $3.2M+46.8% | $2.9M+35.7% | $2.6M+186.2% | $2.4M+221.2% | $2.2M+41.1% | $2.1M+37.5% |
| Non-Current Liabilities | $0 | $0 | $0 | $0 | $0-100.0% | $0-100.0% | $0-100.0% | $0 |
| Long-Term Debt | $2.6M+35.0% | $2.4M+34.0% | $2.1M | $2.0M | $1.9M+57.2% | $1.8M+78.2% | N/A | N/A |
| Total Equity | -$3.9M-54.8% | -$4.1M-73.5% | -$3.2M-46.8% | -$2.9M-37.9% | -$2.5M-32.3% | -$2.4M-46.1% | -$2.2M-55.2% | -$2.1M-54.4% |
| Retained Earnings | -$9.4M-28.1% | -$9.3M-30.1% | -$8.2M-18.7% | -$7.7M-17.0% | -$7.4M-141.3% | -$7.1M-163.8% | -$6.9M-186.4% | -$6.6M-196.2% |
Not reported in any period shown, so not listed: Goodwill.
CBDW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Share Buybacks.
CBDW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, FCF Margin.
Note: Shareholder equity is negative (-$3.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| 1606 CORP CBDW | FY2025 | $0 | N/A | N/A | $134K | — |
| VPR BRANDS LP VPRB | FY2025 | $3.6M | -$1.2M | -33.1% | $7.6M | — |
| HEMPACCO CO INC HPCO | FY2023 | $4.0M | -$13.4M | N/A | $948K | — |
Where 1606 CORP Ranks
Frequently Asked Questions
What is 1606 CORP's annual revenue?
1606 CORP (CBDW) reported $0 in total revenue for fiscal year 2025. This represents a -100.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is 1606 CORP's revenue growing?
1606 CORP (CBDW) revenue declined by 100.0% year-over-year, from $7K to $0 in fiscal year 2025.
How much debt does 1606 CORP have?
As of fiscal year 2025, 1606 CORP (CBDW) had $0 in cash and equivalents against $2.1M in long-term debt.
What are 1606 CORP's total assets?
1606 CORP (CBDW) had $16K in total assets as of fiscal year 2025, including both current and long-term assets.
What is 1606 CORP's current ratio?
1606 CORP (CBDW) had a current ratio of 0.01 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is 1606 CORP's P/E ratio?
1606 CORP (CBDW) has no price-to-earnings ratio at the moment: no net income reported. The market capitalization is $134K as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is 1606 CORP's price-to-sales ratio?
1606 CORP (CBDW) has no price-to-sales ratio at the moment: revenue is not positive (FY2025). The market capitalization is $134K as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Why is 1606 CORP's debt-to-equity ratio negative or not reported?
1606 CORP (CBDW) has negative shareholder equity of -$3.2M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.